Two Sigma Investments LP grew its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 1,101.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 108,067 shares of the company's stock after acquiring an additional 99,070 shares during the quarter. Two Sigma Investments LP owned about 0.06% of Option Care Health worth $2,507,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Cornerstone Investment Partners LLC grew its position in Option Care Health by 3.6% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after acquiring an additional 333 shares in the last quarter. Assetmark Inc. lifted its position in shares of Option Care Health by 2.0% during the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock worth $579,000 after purchasing an additional 487 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after purchasing an additional 537 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after purchasing an additional 681 shares during the period. Finally, Xponance Inc. grew its holdings in shares of Option Care Health by 3.9% in the fourth quarter. Xponance Inc. now owns 25,056 shares of the company's stock valued at $581,000 after purchasing an additional 944 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on OPCH. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of "Moderate Buy" and an average target price of $35.50.
Check Out Our Latest Analysis on Option Care Health
Option Care Health Trading Down 1.2%
NASDAQ:OPCH traded down $0.39 during trading hours on Wednesday, reaching $31.31. 1,804,449 shares of the company were exchanged, compared to its average volume of 1,866,374. The firm has a market cap of $5.13 billion, a price-to-earnings ratio of 26.31, a PEG ratio of 2.30 and a beta of 0.74. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The stock has a 50 day simple moving average of $32.53 and a 200 day simple moving average of $29.81. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the previous year, the business earned $0.26 earnings per share. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. As a group, analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
